Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
6,743,443
-
Share change
-
+10,505
-
Total reported value
-
$19,673,000
-
Price per share
-
$2.92
-
Number of holders
-
16
-
Value change
-
+$25,046
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2016
As of 31 Mar 2016,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,743,443 shares.
The largest 10 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, EverPoint Asset Management, LLC, MILLENNIUM MANAGEMENT LLC, Lombard Odier Asset Management (USA) Corp, Abingworth LLP, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, and Redmile Group, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.